2,250
Views
9
CrossRef citations to date
0
Altmetric
Drug Evaluation

Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis

&
Pages 875-884 | Received 30 Mar 2016, Accepted 27 May 2016, Published online: 20 Jun 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Stefano Giovagnoli, Aurelie Schoubben & Maurizio Ricci. (2017) The long and winding road to inhaled TB therapy: not only the bug’s fault. Drug Development and Industrial Pharmacy 43:3, pages 347-363.
Read now

Articles from other publishers (8)

Nasser Alhajj, Niall J. O'Reilly & Helen Cathcart. (2022) Developing ciprofloxacin dry powder for inhalation: A story of challenges and rational design in the treatment of cystic fibrosis lung infection. International Journal of Pharmaceutics 613, pages 121388.
Crossref
M. D. Manniello, A. Moretta, R. Salvia, C. Scieuzo, D. Lucchetti, H. Vogel, A. Sgambato & P. Falabella. (2021) Insect antimicrobial peptides: potential weapons to counteract the antibiotic resistance. Cellular and Molecular Life Sciences 78:9, pages 4259-4282.
Crossref
Jeffry Weers. (2019) Comparison of Phospholipid-Based Particles for Sustained Release of Ciprofloxacin Following Pulmonary Administration to Bronchiectasis Patients. Pulmonary Therapy 5:2, pages 127-150.
Crossref
The-Thien Tran, Hong Yu, Celine Vidaillac, Albert Y.H. Lim, John A. Abisheganaden, Sanjay H. Chotirmall & Kunn Hadinoto. (2019) An evaluation of inhaled antibiotic liposome versus antibiotic nanoplex in controlling infection in bronchiectasis. International Journal of Pharmaceutics 559, pages 382-392.
Crossref
Chunxia Liu, Ling Lin, Zhengwei Huang, Qiaoli Wu, Junhuang Jiang, Li Lv, Xiaoxia Yu, Guilan Quan, Guocheng Li & Chuanbin Wu. (2019) Novel Inhalable Ciprofloxacin Dry Powders for Bronchiectasis Therapy: Mannitol–Silk Fibroin Binary Microparticles with High-Payload and Improved Aerosolized Properties. AAPS PharmSciTech 20:2.
Crossref
Prakash Khadka, Jack Dummer, Philip C. Hill & Shyamal C. Das. (2018) Considerations in preparing for clinical studies of inhaled rifampicin to enhance tuberculosis treatment. International Journal of Pharmaceutics 548:1, pages 244-254.
Crossref
The-Thien Tran, Celine Vidaillac, Hong Yu, Valerie F.L. Yong, Dan Roizman, Ravishankar Chandrasekaran, Albert Y.H. Lim, Teck Boon Low, Gan Liang Tan, John A. Abisheganaden, Mariko Siyue Koh, Jeanette Teo, Sanjay H. Chotirmall & Kunn Hadinoto. (2018) A new therapeutic avenue for bronchiectasis: Dry powder inhaler of ciprofloxacin nanoplex exhibits superior ex vivo mucus permeability and antibacterial efficacy to its native ciprofloxacin counterpart. International Journal of Pharmaceutics 547:1-2, pages 368-376.
Crossref
Graham Cope. (2017) Bronchiectasis—a growing respiratory problem. Nurse Prescribing 15:10, pages 486-490.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.